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Background: A high-calorie diet and physical inactivity, an imbalance between caloric intake and energy consumption,
are major causes of metabolic syndrome (MetS), which manifests as accumulation of visceral fat and insulin resistance.
However, the lifestyle-related factors associated with visceral fat mass in healthy men are not fully understood.
Methods: We evaluated visceral fat area (VFA), skeletal muscle mass, caloric intake, and energy expenditure in 67
healthy male participants (mean age, 36.9 ± 8.8 years; body mass index 23.4 ± 2.5 kg/m2).
Results: Multiple regression analysis showed that the total skeletal muscle mass (P < 0.001) were negatively and age
(P < 0.001) were positively associated with VFA. Lower limb muscle mass (P < 0.001) was strongly associated with VFA.
However, total caloric intake, total energy expenditure, and energy expenditure during exercise were not associated
with VFA.
Conclusions: Skeletal muscle mass especially lower limb muscle mass negatively contributes to visceral fat mass in
healthy men. Therefore, maintaining lower limb muscular fitness through daily activity may be a useful strategy for
controlling visceral obesity and metabolic syndrome.
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The imbalance between caloric intake and energy con-
sumption, high-calorie diets and physical inactivity, are
major causes of metabolic syndrome (MetS), which
manifests as accumulation of visceral fat and insulin re-
sistance [1]. The prevention of MetS is an important
issue, as it is a major cause of cardiovascular disease
(CVD) [2,3].
Lifestyle intervention including caloric restriction and
exercise is the preferred approach to reduce the inci-
dence of MetS [4,5]. Exercise not only increases energy
consumption but also improves muscle metabolism
through increased glucose uptake in skeletal muscles
[6]. In addition, exercise enhances skeletal muscle mass,* Correspondence: syagi@tokushima-u.ac.jp
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unless otherwise stated.suggesting that skeletal muscle mass could be a param-
eter of exercise duration and intensity. Exercise prevents
visceral obesity [7]; however, the relashonship between
viseral obesity and skeletal muscle mass remains
unclear.
The American Heart Association therefore recom-
mends weight reduction to a BMI of <25 kg/m2) with
exercise duration of at least 30 min performed 5 times a
week at moderate intensity [1]; however, it is unclear
which exercise should be used and which skeletal mus-
cles should be targeted to effectively reduce visceral fat
mass in healthy subjects. Since the prevalence of MetS is
increasing worldwide, healthy subjects are potentially at
risk of MetS [8-10]. Therefore, it is important to identify
the risk factors for visceral fat obesity in healthy subjects
to prevent MetS. In order to clarify these issues, we eva-
luated visceral fat mass, skeletal muscle mass, caloric in-
take, and energy consumption in healthy Japanese men. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Clinical characteristics of subjects
Variables (n = 67) Mean ± SD
Age (years) 36.9 ± 8.8
BW (kg) 69.2 ± 8.3
BMI (kg/m2) 23.4 ± 2.5
Waist circumference (cm2) 84.2 ± 7.4
VFA (cm2) 75.0 ± 29.5
VFAI (cm2) 41.0 ± 14.7
SFA (cm2) 160.3 ± 56.9
SFAI (cm2) 87.6 ± 27.7
Fat weight (kg) 15.1 ± 5.3
Fat weight/BW (%) 21.5 ± 5.6
Skeletal muscle weight
Total body (kg) 30.4 ± 3.0
Total body/BW(%) 44.3 ± 0.03
Upper limbs, (kg) 5.8 ± 0.7
Upper limbs/BW, (%) 8.3 ± 0.7
Lower limbs (kg) 17.5 ± 1.9
Lower limbs/BW (%) 25.5 ± 2.3
Truncal muscle (kg) 7.1 ± 0.9
Truncal muscle/BW (%) 10.3 ± 1.3
BW, body weight; BMI, body mass index; VFA, visceral fat area; VFAI, visceral
fat area index; SFA, subcutaneous fat area; SFAI, subcutaneous fat area index.
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ceral fat mass.
Methods
We recruited 67 healthy male volunteers aged between
20 and 85 years (mean age, 36.9 ± 8.8 years; body mass
index (BMI) 23.4 ± 2.5 kg/m2). Visceral fat area (VFA)
and subcutaneous fat area (SFA) were measured using a
fat area analyzer (Dual Scan HDS-2000®; Omron, Japan)
[11,12]. Studies have shown that the correlation co-
efficient between VFA measured by the fat area analy-

























Figure 1 Waist circumference, BMI, and SFA are associated with VFA.
area, BSA: body surface area.r = 0.88 (p < 0.001) [12]. The repeatability of the fat area
analyzer was evaluated by the Bland–Altman plot,
which has been described elsewhere [12]. These data in-
dicate that this indirect measurement of VFA has a high
correlation coefficient with VFA evaluated by computed
tomography and does not involve X-ray exposure. Be-
cause VFA and SFA were compared with obesity-related
variables, which were adjusted with body size repre-
sented by body surface area or body weight, VFA and
SFA were indexed with body surface area (BSA) as vis-
ceral fat area index (VFAI) and subcutaneous fat area
index (SFAI), respectively. Skeletal muscle mass was
measured with a body composition analyzer (Inbody
7200®; Biospace, Korea) [13]. Body weight and waist cir-
cumstance were measured, and BMI was calculated as
an index of obesity.
Energy expenditure and total caloric intake was cal-
culated using a questionnaire for food and exercise
frequency. Energy expenditure during exercise was
defined as energy consumed during exercise per day.
Total energy expenditure was defined as energy con-
sumed for daily activity, which includes energy expen-
diture during exercise. Total caloric intake, energy
expenditure during exercise, and total energy expen-
diture were assessed for 7 days. These values were then
averaged per day [14,15].
The study protocol was approved by the Ethics
Committee at the Tokushima University Hospital.
Statistical analysis
For continuous variables, each value is expressed as the
mean ± SD. Single regression analysis was used to assess
the correlation between VFA and obesity-related para-
meters. The degree of association among independent
variables, including VFAI, age, skeletal muscle mass,
energy expenditure, caloric intake, and parts of skeletal
muscles, was assessed by multiple regression analyses
(stepwise regression model). All statistical analyses were
performed using SPSS software. Statistical significance












VFA: visceral fat area, BMI: body mass index, SFA: subcutaneous fat
Age (y.o.)









































































Figure 2 Age is positively associated with increased VFA, while total skeletal muscle mass is negatively associated with both VFA and
SFA. Upper and lower skeletal muscle mass are negatively associated with VFA. VFA: visceral fat area, SFA: subcutaneous fat area, BSA: body
surface area, BW: body weight.
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Clinical characteristics of subjects
The clinical characteristics of the subjects are presented
in Table 1.
VFAI is inversely associated with skeletal muscle mass
and energy expenditure
The VFAI was positively associated with waist circum-
ference, BMI, SFAI (Figure 1), and age (Figure 2), but














Figure 3 Total energy expenditure for daily-life activity and energy exp
VFA. VFA: visceral fat area, BSA: body surface area, BW: body weight.skeletal muscle mass (Figure 2). The SFAI was negatively
associated with total skeletal muscle mass (Figure 2).
Neither SFAI nor skeletal muscle mass was associated
with age (data not shown).
The VFAI was negatively associated with total energy
expenditure and energy expenditure during exercise
(Figure 3), but there was no relationship between total
caloric intake and VFAI (data not shown).
Stepwise multiple regression analysis showed that total














enditure during exercise are negatively associated with increased
Table 2 Multiple regression analysis for determinants of visceral fat area
Variables Coefficient 95% Confidence interval Standardized coefficient P value
Total skeletal muscle mass −295 −404 to −187 −0.51 <0.001
Age 0.63 0.32 to 0.94 0.38 <0.001
R2 = 0.45, P < 0.001.
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take, total energy expenditure, and energy expenditure
during exercise were statistically excluded (Table 2).
VFAI is inversely associated with lower limb skeletal
muscle mass
In order to clarify which part of skeletal muscle, inclu-
ding upper limb, lower limb, and truncal skeletal muscle,
influences the volume of visceral fat, we performed step-
wise multiple regression analysis. Although lower limb
skeletal muscle mass was a negative and age was a posi-
tive determinant of VFA, upper limb and truncal skeletal
muscle mass were statistically excluded (Table 3).
Discussion
The lifestyle-related factors associated with visceral fat
mass has been unknown. In this study, we showed that
skeletal muscle mass especially lower limb muscle mass
are negatively associated with VFAI.
We showed that the VFAI is positively associated with
age and negatively associated with skeletal muscle mass.
VFA is positively associated with number of metabolic
risk factors in the elderly [16], and skeletal muscle mass
is inversely associated with age [17,18]. However, our
data showed that skeletal muscle mass was not asso-
ciated with age, which is supported by the evidence that
muscular strength is inversely associated with the inci-
dence of MetS, independently of age [19]. Although the
age outliers might have affected the results (Additional
file 1), they nevertheless indicate that the decrease in
skeletal muscle mass can be prevented by physical
activity.
Decreased skeletal muscle mass leads to physical in-
activity [20]. Conversely, physical inactivity leads to
decreased skeletal muscle mass [20]. Decreased skeletal
muscle mass and strength is associated with increased
morality [21,22]. Sarcopenic obesity is also associated
with hypertension, independent of abdominal obesityTable 3 Multiple regression analysis for determinants of visce
Variables Coefficient 95% Confid
Age 0.52 0.20 t
Lower limb muscle weight −6.78 −9.19 t
Upper limb muscle weight -
Truncal muscle weight -
R2 = 0.46, P < 0.001.[23]. Increasing skeletal muscle mass and strength via
daily exercise may therefore prevent MetS and prolong
life span.
In addition, in patients with metabolic syndrome, vis-
ceral fat accumulation is accompanied by excess lipid
deposition in skeletal muscle, which may contribute
to impaired glucose uptake leading to insulin resistance
[24]. Improved skeletal muscle functions (including me-
tabolic system) through exercise may contribute to the
prevention of MetS [25].
The American Heart Association recommends daily
exercise to prevent the accumulation of abdominal fat
[1]. Although some subjects exercised in their spare
time, our results showed that the association between
total energy expenditure during daily activity and VFAI
was stronger than the association between energy ex-
penditure during exercise and VFAI. Because the du-
ration of energy expenditure during exercise is relatively
short, it may be insufficient for reducing VFA. Therefore,
the length of continuous caloric consumption is impor-
tant for reducing VFA. Enhanced energy expenditure
combined with daily exercise is essential for reducing
the volume of visceral fat.
Lower limb muscle mass is a determinant of VFAI.
Lower limb muscle including the quadriceps forms the
largest muscle mass in the body and may therefore con-
tribute to decreased VFA to a greater extent than upper
limb or truncal muscle. Lower limb muscle mass and
performance in gait are also important because they are
associated with reduced mobility, a poor quality of life,
CVD, and death [26-28]. Increased physical activity and
daily lower body exercise (e.g., brisk walking, cycling,
and stair climbing) may be the most useful way to re-
duce visceral fat and improve mortality. Increased daily
activity in young- and middle-aged men may prevent
MetS and CVD by decreasing the volume of visceral fat.
In conclusion, skeletal muscle mass especially lower
limb muscle mass negatively contributed to VFA inral fat area
ence interval Standardized coefficient P value
o 0.84 0.31 <0.01
o −4.36 −0.53 <0.001
- - -
- - -
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through daily exercise may therefore be a useful strategy
for controlling visceral obesity and MetS.
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